Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-10-11

Clinical Trial Update: ADALISKIAS: Adalimumab for Acute Disc Prolapse [Phase 3]

View source ↗

Summary

A Phase 3 trial update on adalimumab for acute lumbar disc herniation (disc prolapse), with the current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Kuopio University Hospital | Conditions: Disc Prolapse, Pain | Phase 3 | Status: UNKNOWN